Furthermore, pharmacological inhibition of EphA2 by the small molecule inhibitor ALW-II-41-27 reduced the proliferation of SUN-resistant tumor cells, suppressed tumor growth in vivo, and restored the sensitivity of SUN-resistant tumor cells to SUN in vitro and in vivo. Here, EPHA2 is linked to neoplasm.